Home  |  Publications  |  Conferences   |  Join  |  Contact
                           
 
ISSN: 2329-6917

Journal of Leukemia

Open Access
 
 
home » journals » leukemia
 
 

Upcoming Special Issues

Special issue entitled: "Myeloma" has been edited by
Editor Image

Guido J.K. Tricot
Professor of Medicine
University of Iowa Hospitals and Clinics
Iowa City, Iowa, USA
Tel: 319-356-3425
 

University Logo
Special issue entitled: "Bone Marrow Transplantation" has been edited by
Editor Image

Susumu Ikehara
Professor
Department of Stem Cell Disorders
Kansai Medical University
Japan
Tel: 81-72-804-2450
 

University Logo
Read More»
 

About the Journal

Leukemia is malignancy of any cellular element in the blood or bone marrow. Journal of Leukemia (JL) is a peer reviewed medical journal that includes a wide range of fields in leukemias, lymphomas, multiple myeloma, epidemiologic studies and other hematologic malignancies and creates a platform for the authors to make their contribution towards the journal and the editorial office promises peer process for the submitted manuscripts to ensure quality.
JL is one of the best open access journals that aims to publish the most complete and reliable source of information on discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in the field and provide  online access without any restrictions or any other subscriptions to researchers worldwide
This scholarly open access journal is using Editorial Tracking System to maintain quality in the review process. Editorial Tracking is an online manuscript submission, review and the progress of the article. Review processing is performed by the editorial board members of Journal of Leukemia or outside experts; at least two independent reviewer’s approval followed by the editor is required for the acceptance of any citable manuscript. Authors may submit manuscripts and track its progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.
Journal of Leukemia is an Open Access journal and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.
OMICS Group International is a leading Open Access publisher that publishes more than 500+ peer-reviewed Open Access Journals and organizes over 300+ International Conferences globally with the support of nearly 1000 International Societies. OMICS Publishing Group journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities and the rapid, quality and quick review processing.
The journal is using Editorial manager System for quality in review process. Editorial manager System is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Leukemia or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process

Submit manuscript at http://www.editorialmanager.com/biomedicaljournals/ or send as an e-mail attachment to the Editorial Office at editor.jlu@omicsonline.org

Journal of Leukemia is organizing 5th World Conference on Cancer Therapy during september 28-30, 2015 Atlanta, USA with the theme of Exploring the Possibilities towards cancer treatment.
Aims and Scope
 

Recently published articles

 
12-O-Tetradecanoylphorbol-13-Acetate for Refractory Secondary Acute Myeloid Leukemia

Quande Lin, Baijun Fang, Yufu Li, Jianwei Du and Yongping Song

 
Decreased Expression Levels of Tumor Suppressor MicroRNAs in Hairy Cell Leukemia

Zsuzsanna Gaal, Balint Laszlo Balint, Laszlo Rejto and Eva Olah

 
Burden of Tyrosine Kinase Inhibitor Failure in Patients with Chronic Myeloid Leukemia

Patricia Kropf, Gisoo Barnes, Boxiong Tang, Ashutosh Pathak and Jean-Pierre Issa

 
Chronic Myeloid Leukemia Presenting with Priapism

Farhan S, Anjum F, Al-Qahtani FS and Al-Anazi KA

 
Thymic Immunophenotype, and Expression of CD4 and Myeloid Antigens is Associated with Outcome in Adult Patients with T�Cell Acute Lymphoblastic Leukemia

Areej Al Mugairi, Bakul I Dalal1, Steven Pi, Soo Yeon Lee, Nikisha S Khare, Jason Pal, Alok Vakil, Adam Bryant, Sally Lau and Yasser R Abou Mourad

 
 
 
 
 
 
© 2008-2015 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version